Acetyl Hexapeptide-3 (Argireline) inhibits the release of neurotransmitters as it interferes with the formation and stabilization of the protein complex needed for docking vesicles of acetylcholine release. In an open study often female subjects, a serum containing this peptide was applied twice a day. After 1 month, the results showed a reduction in periorbital wrinkle depth of 27%. The in vitro effect of neurotransmitter-inhibiting peptides is to inhibit the release of neurotransmitters, while the desired, in vivo, effect is to reduce facial wrinkles caused by a decrease in muscle activity. Research tests were performed using a combination of both actives in order to evaluate a possible synergy or additive effect. A cream/serum containing 5% argireline solution (0.05%) and 5% leuphasyl solution (0.05%) was applied twice daily around the eyes of 15 volunteers, aged 39 to 63, for 28 days. A decrease of 24.62% was accomplished, with maximum values up to –46.53%. Both peptides show additive effects due to their complementary mechanisms.
Ipamorelin (5mg x 10), CJC-1295 no DAC (5mg x 10)
Original price was: $955.00.$811.00Current price is: $811.00.
Adipotide (FTPP) 10mg
$89.00
New
Acetyl Hexapeptide-3 (Argireline) 200mg (Topical)
$220.00
Acetyl Hexapeptide-3 (Argireline) inhibits the release of neurotransmitters as it interferes with the formation and stabilization of the protein complex needed for docking vesicles of acetylcholine release.
Description
Shipping & Delivery
Related products
AICAR 50mg
AICAR is an analogue of adenosine monophosphate. It has been used clinically to protect against cardiac ischemia following heart attack. AICAR has antioxidant properties and may therefore help to slow the physiologic signs of aging. There is ongoing research into the use of AICAR to mediate the effects of diabetes, auto-immune diseases, and other inflammatory conditions.
Gut Inflammation (60 Capsules) (Stable BPC-157 Arginate, KPV, Larazotide) FREE Shipping
BPC-157 Arginate Salt is very stable in human gastric juice and boosts the oral bioavailability from less than 3% to greater than 90%. BPC 157 arginate salt is also more stable in varied temperature environments and can resist the effects of UV light. Studies show that just 5% of BPC 157 arginate is degraded after 5 hours in gastric acid as compared to 98% of the acetate salt with oral administration. The enhanced oral bioavailability of the arginate salt makes it the preferred choice in BPC 157 oral research.
MK-677 (Ibutamoren) 12.5mg (60 Capsules)
MK-677, is a orally bio-active, selective agonist of the ghrelin receptor. Research shows that MK-677 increases the natural secretion of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), but does not affect cortisol levels. It is being researched as a possible treatment for GH deficiency, muscle and bone wasting, appetite stimulation and Alzheimer's disease. MK-677 research in mice, appeared to prevent the onset of AD, even in genetically predisposed mice, as long as it was started before significant amyloid beta accumulation. MK-677 research has also shown exceptionally promising benefits in improving sleep quality.
Orforglipron (6mg x 90 Capsules)
OS-01 (100mg x 30 Capsules)
OS-01 is an AMP-activated protein kinase (AMPK) activator that modulates cellular energy homeostasis and metabolic function. AMPK, a central regulator of energy balance, is activated in response to low intracellular ATP levels, enhancing glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. OS-01 stimulates AMPK phosphorylation, leading to increased ATP production, improved insulin sensitivity, and enhanced autophagic flux, thereby promoting cellular repair and longevity. This compound has been shown to mitigate oxidative stress by downregulating reactive oxygen species (ROS) and inflammatory cytokines, reducing cellular damage and aging-related dysfunction. Additionally, OS-01 enhances endurance by optimizing energy substrate utilization and preserving glycogen stores during exercise. It plays a protective role in renal and cardiovascular systems by attenuating fibrosis, reducing endothelial dysfunction, and improving mitochondrial efficiency. Preclinical studies suggest its potential in managing metabolic disorders, including type 2 diabetes, obesity, and cardiovascular diseases, by improving glucose homeostasis and reducing insulin resistance. Furthermore, OS-01’s activation of autophagy contributes to neuroprotection, reducing age-related neurodegeneration. Its multifaceted mechanism positions it as a promising candidate for therapeutic intervention in metabolic and age-related diseases.
TB-500 (Thymosin Beta-4) (43aa)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Reviews
There are no reviews yet.